Inactive Instrument

Calendar Orgenesis Inc Other OTC

Equities

US68619K1051

Chart calendar Orgenesis Inc

6ff63eedbe8036e4afbcf597.N42s7iYuQiRgZ7gKcbDaKOx1S_vK5UziRrc3N0NUz1Q.BtXCthNEMFAjJZVeLsq9R4gGBrGOrXiqdfhhWQozqBoa7sjWX38wfi82-Q~4d96ed8a304ce4b1a22f3e43b5b881e8

Upcoming events on Orgenesis Inc

12/08/2024 Q2 2024 Earnings Release (Projected)
07/11/2024 Q3 2024 Earnings Release (Projected)
12/02/2025 Q4 2024 Earnings Release (Projected)

Past events on Orgenesis Inc

27/06/2024 15:00 Annual General Meeting
15/04/2024 22:07 Q4 2023 Earnings Release
19/03/2024 13:10 Bioprocessing Europe Summit
13/11/2023 21:15 Q3 2023 Earnings Release
11/08/2023 13:00 Q2 2023 Earnings Call
11/08/2023 12:00 Q2 2023 Earnings Release
08/06/2023 15:00 Annual General Meeting - M&A Vote
22/05/2023 Benchmark Company Healthcare House Call Virtual Conference
10/05/2023 21:30 Q1 2023 Earnings Release
26/04/2023 18:15 INTERPHEX Conference
21/03/2023 15:00 Q4 2022 Earnings Call
21/03/2023 12:00 Q4 2022 Earnings Release
11/11/2022 13:00 Q3 2022 Earnings Call
11/11/2022 10:30 Q3 2022 Earnings Release
27/10/2022 02:30 TIL Therapies Summit
16/08/2022 16:00 Interim 2022 Earnings Call
16/08/2022 15:23 Interim 2022 Earnings Release
24/05/2022 12:00 Q1 2022 Earnings Release
30/03/2022 17:00 FY 2021 Earnings Call
30/03/2022 12:00 FY 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022
Net sales
Million USD
Released
Forecast
Spread
33,3
33,5
-0.73%
0,00


35,5
37,6
-5.58%
36,0
30,7
17.35%
EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00


0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-24,6
-22,4
-9.84%
0,00


-16,8
-11,5
-46.09%
-7,54
-8,00
5.74%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-25,5
-22,3
-14.25%
0,00


-18,0
-11,5
-56.1%
-12,0
-9,20
-30%
Net income
Million USD
Released
Forecast
Spread
-24,1
-21,8
-10.65%
1,11


-18,1
-11,5
-56.98%
-14,9
-9,20
-61.84%
EPS
USD
Released
Forecast
Spread
-1,77
-1,37
-29.2%
0,29


-0,74
-0,47
-57.45%
-0,59
-0,37
-59.46%
Announcement Date09/03/2009/03/2130/03/2222/03/23

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales
Million USD
Released
Forecast
Spread
7,21
6,30
14.48%
7,20
7,00
2.87%
7,99
7,30
9.42%
13,6
8,30
64.14%
7,04
9,90
-28.85%
6,98
10,7
-34.81%
0,11
13,5
-99.19%
EBIT
Million USD
Released
Forecast
Spread
-3,24
-0,90
-259.56%
-4,73
-0,60
-688.67%
-0,01
-0,50
98.6%
0,43
0,00
-
-3,21
1,30
-346.54%
-3,33
1,70
-295.82%
-2,24
2,60
-185.96%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-4,00
-0,90
-344%
-5,48
-0,60
-813.5%
-1,38
-0,50
-176.6%
-1,10
0,00
-
-4,13
1,30
-417.85%
-3,57
1,70
-310%
-12,3
2,60
-571.5%
Net income
Million USD
Released
Forecast
Spread
-4,01
-0,90
-345.44%
-5,43
-0,60
-804.5%
-1,36
-0,50
-171.2%
-4,10
0,00
-
-4,19
1,30
-422.23%
-4,13
1,70
-342.76%
-12,7
2,60
-586.65%
EPS
USD
Released
Forecast
Spread
-0,16
-0,04
-300%
-0,22
-0,02
-1000%
-0,05
-0,02
-150%
-0,16
0,00
-
-0,16
0,05
-420%
-0,15
0,06
-350%
-0,43
0,10
-530%
Announcement Date23/05/2215/08/2210/11/2222/03/2310/05/2310/08/2313/11/23